Biotechnology News and Research

RSS

5,000-Year-Old Cave Bacterium Resists Antibiotics and Kills Pathogens

Psychrobacter SC65A.3, preserved in cave ice, harbors multidrug resistance genes and exhibits antimicrobial activity, offering insights into ancient resistomes.

26 Feb 2026

Precision Gene Editing Redefines Fruit Color in Polyploid Strawberry

Strawberry fruit color is primarily determined by anthocyanins, pigments synthesized through a tightly regulated metabolic pathway.

24 Feb 2026

Machine Learning Enhances Manufacturing of Complex Protein Drugs

Industrial yeasts are a powerhouse of protein production, used to manufacture vaccines, biopharmaceuticals, and other useful compounds.

18 Feb 2026

Genomic Tools Accelerate American Chestnut Restoration Efforts

For more than a century, scientists and conservationists have tried to bring back the American chestnut, a tree once so common it shaped forests across the eastern United States.

16 Feb 2026

Complete Flax Genome Assembly Advances Fatty Acid Research

Flax (Linum usitatissimum L.) is one of the richest plant sources of alpha-linolenic acid, an essential omega-3 fatty acid linked to human health benefits ranging from cardiovascular protection to metabolic regulation.

13 Feb 2026

Plant Scientists Tackle Major Threat to UK Wheat

A fungus known as yellow rust can destroy wheat, reducing harvests and driving up prices, which in turn can affect the price of staple foods like bread and pasta.

13 Feb 2026

SeekGene Joins Human Cell Atlas Consortium to Advance Multiomics Research

SeekGene, a biotechnology company focused on "driving the development and democratization of innovative single-cell technologies", announced it has officially joined the Human Cell Atlas (HCA) Commercial Discount Program, providing eligible consortium members with exclusive commercial discounts on its single-cell platforms and assays to support large-scale cell atlas research worldwide.

12 Feb 2026

The Genetic Mechanics of Bacterial Circadian Clocks

Circadian clocks play an important role in our health and well-being by synchronizing the 24-hour biological cycles with light and dark exposure. Disruptions in the rhythms of these clocks, such as jet lag and daylight saving time, might put their everyday operations out of sync.

11 Feb 2026

Machine Learning Model Accelerates Manufacturing Timeline of Monoclonal Antibodies

As instigators of immunity, monoclonal antibodies are marvels of modern medicine, lab-made proteins that can treat cancers, autoimmune diseases, and many other conditions.

10 Feb 2026

Cells Use Protein Partnership to Manage Oxidative Stress

Cornell researchers have discovered a new way cells regulate how they respond to stress, identifying an interaction between two proteins that helps keep a critical cellular recycling system in balance.

10 Feb 2026

Powerful New Enzyme Efficiently Synthesizes RNA

From vaccines and diagnostics to emerging gene-based therapies, RNA molecules are now central to modern medicine.

10 Feb 2026

Selective Mitophagy Enables Invasive Growth of Anthracnose Pathogen

Anthracnose is one of the most damaging fungal diseases affecting woody oil crops and many other plants, causing severe yield losses worldwide.

4 Feb 2026

Sugar Molecules Point to a New Weapon Against Drug-Resistant Bacteria

Australian researchers have developed a powerful new way to target deadly, drug-resistant bacteria by designing antibodies that recognize a sugar found only on bacterial cells – an advance that could underpin a new generation of immunotherapies for multidrug resistant hospital-acquired infections.

4 Feb 2026

New Map Reveals How Cancer Gene Mutations Influence Tumor Growth

Scientists have created a complete map showing how hundreds of possible mutations in a key cancer gene influence tumor growth.

3 Feb 2026

Expanding the Biosynthetic Capabilities of Microbes Using Light

Researchers are continually looking for new ways to hack the cellular machinery of microbes like yeast and bacteria to make products that are useful for humans and society.

2 Feb 2026

Cellares Raises $257 Million Series D Led by BlackRock and Eclipse to Industrialize Global Cell Therapy Manufacturing with Breakthrough Automation

Cellares, the first Integrated Development and Manufacturing Organization (IDMO), today announced a $257 million Series D financing co‑led by investment funds managed by BlackRock and Eclipse, bringing the company's total capital raised to $612 million.

From Cellares 30 Jan 2026